FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * NAGJI BANSI 2. Issuer Name and Ticker or Trading Symbol GoodRx Holdings, Inc. [ GDRX ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
President, Healthcare
(Last)         (First)         (Middle)
C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD
3. Date of Earliest Transaction (MM/DD/YYYY)
9/14/2021
(Street)
SANTA MONICA, CA 90404
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock  9/14/2021    M    89797  A $6.84  89797  D   
Class A Common Stock  9/14/2021    S(1)    89797  D $45.0129 (2) 0  D   
Class A Common Stock  9/15/2021    M    60415  A $6.84  60415  D   
Class A Common Stock  9/15/2021    S(1)    60415  D $45.0288 (3) 0  D   
Class A Common Stock  9/16/2021    M    29788  A $6.84  29788  D   
Class A Common Stock  9/16/2021    S(1)    29788  D $45.0345 (4) 0  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)  $6.84  9/14/2021    M        89584    (5) 6/15/2030  Class A Common Stock  89797  $0.00  481250  D   
Stock Option (Right to Buy)  $6.84  9/14/2021    M        213    (6) 6/15/2030  Class A Common Stock  213  $0.00  399787  D   
Stock Option (Right to Buy)  $6.84  9/15/2021    M        60415    (6) 6/15/2030  Class A Common Stock  60415  $0.00  339372  D   
Stock Option (Right to Buy)  $6.84  9/16/2021    M        29788    (6) 6/15/2030  Class A Common Stock  29788  $0.00  309564  D   

Explanation of Responses:
(1)  The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
(2)  This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.11. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(3)  This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.24. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(4)  This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.13. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(5)  The option has vested and became exercisable or will vest and become exercisable with respect to the original 700,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on June 10, 2020.
(6)  The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the shares monthly thereafter until fully vested on June 10, 2024.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
NAGJI BANSI
C/O GOODRX HOLDINGS, INC.
2701 OLYMPIC BOULEVARD
SANTA MONICA, CA 90404


President, Healthcare

Signatures
/s/ Gracye Cheng, as Attorney-in-Fact for Bansi Nagji 9/16/2021
**Signature of Reporting Person Date
GoodRx (NASDAQ:GDRX)
Historical Stock Chart
From Sep 2021 to Oct 2021 Click Here for more GoodRx Charts.
GoodRx (NASDAQ:GDRX)
Historical Stock Chart
From Oct 2020 to Oct 2021 Click Here for more GoodRx Charts.